Current crisis or artifact of surveillance: insights into rebound chlamydia rates from dynamic modelling
Tóm tắt
After initially falling in the face of intensified control efforts, reported rates of sexually transmitted chlamydia in many developed countries are rising. Recent hypotheses for this phenomenon have broadly focused on improved case finding or an increase in the prevalence. Because of many complex interactions behind the spread of infectious diseases, dynamic models of infection transmission are an effective means to guide learning, and assess quantitative conjectures of epidemiological processes. The objective of this paper is to bring a unique and robust perspective to observed chlamydial patterns through analyzing surveillance data with mathematical models of infection transmission. This study integrated 25-year testing volume data from the Canadian province of Saskatchewan with one susceptible-infected-treated-susceptible and three susceptible-infected-treated-removed compartmental models. Calibration of model parameters to fit observed 25-year case notification data, after being combined with testing records, placed constraints on model behaviour and allowed for an approximation of chlamydia prevalence to be estimated. Model predictions were compared to observed case notification trends, and extensive sensitivity analyses were performed to confirm the robustness of model results. Model predictions accurately mirrored historic chlamydial trends including an observed rebound in the mid 1990s. For all models examined, the results repeatedly highlighted that increased testing volumes, rather than changes in the sensitivity and specificity of testing technologies, sexual behaviour, or truncated immunological responses brought about by treatment can, explain the increase in observed chlamydia case notifications. Our results highlight the significant impact testing volume can have on observed incidence rates, and that simple explanations for these observed increases appear to have been dismissed in favor of changes to the underlying prevalence. These simple methods not only demonstrate geographic portability, but the results reassure the public health effort towards monitoring and controlling chlamydia.
Tài liệu tham khảo
Brunham RC, Rey-Ladino J: Immunology of chlamydia infection: implications for a chlamydia vaccine. Nat Rev Immunol. 2005, 5: 149-161. 10.1038/nri1551.
Morrison RP, Caldwell HD: Immunity to murine chlamydial genital infection. Infect Immun. 2002, 70: 2741-2751. 10.1128/IAI.70.6.2741-2751.2002.
Brunham RC, Rekart ML: The arrested immunity hypothesis and the epidemiology of chlamydia control. Sex Transm Dis. 2008, 35: 53-54. 10.1097/OLQ.0b013e31815e41a3.
Rekart ML, Brunham RC: Epidemiology of chlamydial infection: are we losing ground?. Sex Transm Infect. 2008, 84: 87-91. 10.1136/sti.2007.027938.
Public Health Agency of Canada: Canadian guidelines on sexually transmitted infections. [http://www.phac-aspc.gc.ca/std-mts/sti-its/guide-lignesdir-eng.php]
Low N: Screening programmes for chlamydial infection: when will we ever learn?. Br Med J. 2007, 334: 725-728. 10.1136/bmj.39154.378079.BE.
Regan DG, Wilson DP, Hocking JS: Coverage is the key for effective screening of Chlamydia trachomatis in Australia. J Infect Dis. 2008, 198: 349-358. 10.1086/589883.
Miller WC: Epidemiology of chlamydia infection: are we losing ground?. Sex Transm Infect. 2008, 84: 82-86. 10.1136/sti.2007.028662.
Low N: Caution: chlamydia surveillance data ahead. Sex Transm Infect. 2008, 84: 80-81. 10.1136/sti.2008.030338.
Sterman JD: Learning from Evidence in a Complex World. Am J Public Health. 2006, 96: 505-514. 10.2105/AJPH.2005.066043.
Hethcote HW, Yorke JA: Gonorrhea Transmission Dynamics and Control. Lecture Notes in Biomathematics. 1984, Berlin: Springer-Verlag
Saskatchewan Health Covered Population 2007. [http://www.health.gov.sk.ca/covered-population2007/main.htm]
Garnett GP, Anderson RM: Sexually transmitted diseases and sexual behavior: insights from mathematical models. J Infect Dis. 1996, 174 (Suppl 2): S150-S161.
Anderson RM, May RM: Infectious Diseases of Humans: Dynamics and Control. 1991, Oxford: Oxford University Press
Driessche van den P, Watmough J: Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math Biosci. 2002, 180: 29-48. 10.1016/S0025-5564(02)00108-6.
Velde Van de N, Brisson M, Boily MC: Modeling Human Papillomavirus Vaccine Effectiveness: quantifying the impact of Parameter Uncertainty. Am J Epidemiol. 2007, 165: 762-775. 10.1093/aje/kwk059.
Garnett GP, Bowden FJ: Epidemiology and control of curable sexually transmitted diseases: opportunities and problems. Sex Transm Dis. 2000, 27: 588-599. 10.1097/00007435-200011000-00007.
White PJ, Ward H, Cassell JA, Mercer CH, Garnett GP: Vicious and virtuous cycles in the dynamics of infectious diseases and the provision of health care: gonorrhea in Britain as an example. J Infect Dis. 2005, 192: 824-36. 10.1086/432004.
Burckhardt F, Warner P, Young H: What is the impact of change in diagnostic test method on surveillance data trends in Chlamydia trachomatis infection?. Sex Transm Infect. 2006, 82: 24-30. 10.1136/sti.2004.011882.
Forward KR: The impact of switching to polymerase chain reaction for the diagnosis of Chlamydia trachomatis infections in women. Can J Public Health. 2003, 94: 229-232.
Gotz H, Lindback J, Ripa T, Arneborn M, Ramsted K, Ekdahl K: Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods?. Scand J Infect Dis. 2002, 34: 28-34. 10.1080/00365540110077001.
Brunham RC, Pourbohloul B, Mak S, Rekart ML: The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis. 2005, 192: 1836-1844. 10.1086/497341.
Aparicio JP, Pascual M: Building epidemiological models from R0: an implicit treatment of transmission in networks. Proc R Soc B. 2007, 274: 505-512. 10.1098/rspb.2006.0057.
Homer JB: A system dynamics model of national cocaine prevalence. Sys Dynam Rev. 1991, 9: 49-78. 10.1002/sdr.4260090104.
Golden MR, Hughes JP, Brewer DD, Holmes KK, Whittington WL, Hogben M, Malinski C, Golding A, Handsfield HH: Evaluation of a population-based program of expedited partner therapy for gonorrhea and chlamydial infection. Sex Transm Dis. 2007, 34: 598-603.
Schillinger JA, Kissinger P, Calvet H, Whittington WL, Ransom RL, Sternberg MR, Berman SM, Kent CK, Martin DH, Oh MK, Handsfield HH, Bolan G, Markowitz LE, Fortenberry JD: Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women - a randomized, controlled trial. Sex Transm Dis. 2003, 30: 49-56. 10.1097/00007435-200301000-00011.
Brunham RC, Plummer FA: A general model of sexually transmitted disease epidemiology and its implications for control. Med Clin N Am. 1990, 74: 1339-1352.
Parks KS, Dixon PB, Richey CM, Hook EW: Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis. 1997, 24: 229-235.
Morré SA, Brule van den AJ, Rozendaal L, Boeke AJ, Voorhorst FJ, de Blok S, Meijer CJ: The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year of follow-up. Int J Sex Transm Dis AIDS. 2002, 12: 12-18.
Molano M, Meijer CJ, Weiderpass E, Arslan A, Posso H, Franceschi S, Ronderos M, Muñoz N, Brule van den AJ: The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis. 2005, 191: 907-916. 10.1086/428287.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/10/70/prepub